Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Glenmark says clinical...

    Glenmark says clinical trial suspended at Jaipur hospital

    Written by Ruby Khatun Khatun Published On 2018-05-05T14:46:31+05:30  |  Updated On 23 Dec 2022 11:07 AM IST
    Glenmark says clinical trial suspended at Jaipur hospital

    New Delhi: Drug firm Glenmark Pharmaceuticals said it has suspended the clinical trial at the Malpani Hospital in Jaipur as soon as it became aware of the alleged irregularities at the hospital.


    The company has "received the show-cause notice pertaining to the monitoring of the clinical trial at Malpani Hospital...," Glenmark Pharmaceuticals said in a BSE filing.


    Coming out with a clarification on the news reports regarding clinical trial, the company said," As soon as the company became aware of the alleged irregularities at Malpani Hospital, the trials at the site were immediately suspended in the interest of patient safety."


    The company also said that it will respond to the notice in the stipulated time-frame.


    The hospital in Jaipur is one of the many sites that had recently initiated phase II clinical trial for the company's molecule GRC 27864 in patients with moderate osteoarthritis pain, Glenmark said.


    Malpani Hospital is a CDSCO-approved site for clinical trials and has been conducting trials for many companies including multi-nationals over the past several years, it added.


    Read also: Jaipur Hospital, Top Pharma Co face allegations of Conducting Unethical Human drug Trials
    alleged irregularitiesCDSCOClinical TrialGlenmarkGlenmark PharmaceuticalsGRC 27864hospitalJaipurMalpani Hospitalosteoarthritis painshowcause noticesuspended
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok